Detalhe da pesquisa
1.
Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses.
Dev Dyn
; 252(12): 1428-1448, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37435833
2.
Novel Neonatal Umbilical Catheter Protection and Stabilization Device in In vitro Model of Catheterized Human Umbilical Cords: Effect of Material and Venting on Bacterial Colonization.
Am J Perinatol
; 38(6): 560-566, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31739365
3.
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Cancer
; 126(11): 2597-2606, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32208524
4.
Low-Dose Infigratinib Increases Bone Growth And Corrects Growth Plate Abnormalities In An Achondroplasia Mouse Model.
J Bone Miner Res
; 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38590263
5.
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.
JBMR Plus
; 6(8): e10661, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35991529
6.
Does Urinary Bisphenol-A Change after Bariatric Surgery?
J Am Coll Surg
; 227(2): 232-237, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29753982
7.
Ultrasound-Guided Percutaneous Vein Access for Placement of Broviac Catheters in Extremely Low Birth Weight Neonates: A Series of 3 Successful Cases.
J Laparoendosc Adv Surg Tech A
; 25(11): 958-60, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26288340
8.
Obesity-Related Hormones and Metabolic Risk Factors: A Randomized Trial of Diet plus Either Strength or Aerobic Training versus Diet Alone in Overweight Participants.
J Diabetes Obes
; 1(1): 1-7, 2014 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-25599089
9.
The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.
Physiol Behav
; 100(5): 549-59, 2010 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-20452367